TORC1 Suppression Predicts Responsiveness to RAF and MEK Inhibition in <i>BRAF-</i> Mutant MelanomaRyan B. Corcoran, Jeffrey A. Engelman, S. Michael Rothenberg et al.|Science Translational Medicine|2013Cited by 138
Inhibition of mutant EGFR in lung cancer cells triggers SOX2-FOXO6-dependent survival pathwaysS. Michael Rothenberg, Daniel A. Haber, Gaylor Boulay et al.|eLife|2015Cited by 45
Resveratrol induces apoptosis in transformed follicular lymphoma OCI-LY8 cells: Evidence for a novel mechanism involving inhibition of BCL6 signalingAnthony C. Faber, Thomas C. Chiles|International Journal of Oncology|2006Cited by 32
Pharmaceutical Interference of the EWS-FLI1–driven Transcriptome By Cotargeting H3K27ac and RNA Polymerase Activity in Ewing SarcomaDaniel A.R. Heisey, Anthony C. Faber|Molecular Cancer Therapeutics|2021Cited by 19
High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibitionJinyang Cai, Anthony C. Faber|Cell Reports|2022Cited by 18